← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Cambria Biosciences, Llc
Woburn, MA
$9,197,727
Total funding
15
Grants
Funding over time
peak $1.4M · FY2005–07$2M$1.5M$1M$500K$0
'05
'06
'07
Funding mix
By agency
NIH$9,197,727 · 15
By mechanism
U01$4,980,553 · 2
R43$2,616,324 · 10
R44$1,494,253 · 2
R41$106,597 · 1
Investigators at Cambria Biosciences, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
TARGET-BASED SCREENS FOR NOVEL nAChR INSECTICIDES$678,288
U01 · FY2002 · AI
TARGET-BASED SCREENS FOR NOVEL nAChR INSECTICIDES$672,632
U01 · FY2004 · AI
TARGET-BASED SCREENS FOR NOVEL nAChR INSECTICIDES$671,158
U01 · FY2003 · AI
INSECT GLUTAMATE RECEPTORS AS NOVEL INSECTICIDE TARGETS$655,631
U01 · FY2003 · AI
TARGET-BASED SCREENS FOR NOVEL nAChR INSECTICIDES$642,367
U01 · FY2005 · AI
COMPOUNDS ACTIVATING DJ-1 AS THERAPEUTICS FOR PARKINSON'S DISEASE$588,696
R43 · FY2007 · NS
INSECT GLUTAMATE RECEPTORS AS NOVEL INSECTICIDE TARGETS$568,555
U01 · FY2005 · AI
INSECT GLUTAMATE RECEPTORS AS NOVEL INSECTICIDE TARGETS$562,246
U01 · FY2006 · AI
INSECT GLUTAMATE RECEPTORS AS NOVEL INSECTICIDE TARGETS$529,676
U01 · FY2004 · AI
Novel Therapeutic Agents for ALS$494,142
R43 · FY2007 · NS
A C. ELEGANS SCREEN FOR NOVEL ANTINEMATODE DRUGS$475,186
R44 · FY2002 · AI
Development of nuclear receptors as anthelmintic targets$424,255
R44 · FY2002 · AI
Development of nuclear receptors as anthelmintic targets$322,141
R44 · FY2003 · AI
A HIGH-THROUGHPUT SCREEN FOR ANTI-NECROTIC COMPOUNDS$311,142
R43 · FY2006 · NS
PESTICIDE-SYNUCLEIN: RISK FACTORS FOR PARKINSON'S$291,202
R43 · FY2004 · NS
A C. ELEGANS SCREEN FOR NOVEL ANTINEMATODE DRUGS$272,671
R44 · FY2003 · AI
RILUZOLE MOA: TARGETS FOR IMPROVED NEUROPROTECTIVE DRUGS$253,798
R43 · FY2004 · NS
Compounds Targeting Nematode Secretion as Novel Anti-filarial Drugs$206,542
R43 · FY2006 · AI
A TOXIN BASED DROSOPHILA PARKINSON'S DISEASE MODEL$198,515
R43 · FY2005 · ES
Identification and expression of insecticide targets$106,597
R41 · FY2002 · AI